Trial Profile
A Phase II Trial of External Irradiation (50.4 GY) and Weekly Paclitaxel (Taxol) for Non-Metastatic, Unresectable Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 05 Mar 2008 Status changed from in progress to completed, according to ClinicalTrials.gov
- 20 Sep 2005 New trial record.